Global Action Plan for Influenza Vaccines (GAP) is a comprehensive strategy to reduce the present global shortage of influenza vaccines for seasonal epidemics and pandemic influenza in all countries of the world through three major approaches:
- Increase in seasonal vaccine use
- Increase in vaccine production capacity
- Research and development
GAP was launched in 2006 and further refined in 2011.
The first GAP approach is to encourage countries to increase their seasonal vaccine use.
Increased use of seasonal influenza vaccine will reduce disease burden of seasonal influenza infections, contribute towards the preparedness of countries to respond to an eventual pandemic and motivate industry to develop greater capacity for manufacturing vaccines.
The second GAP approach concentrates on increasing production capacity for pandemic vaccines without expectation for a commensurate increase in the demand for seasonal vaccine.
Short term – produce enough vaccine to immunize two billion people; this vaccine should be available on the market six months after transfer of the vaccine prototype strain to industry.
Medium and long term – produce enough vaccine to immunize the world’s population (6.7 billion).
The third GAP approach encourages to use new technologies to develop more potent and effective influenza vaccines that are:
(a) capable of inducing protective responses after one dose, and/or
(b) induce broad-spectrum and long-lasting immunity against both seasonal and pandemic influenza strains.
16 December 2015
Third WHO Consultation on Global Action Plan for Influenza Vaccines (GAP III)
The third and final GAP consultation will take place in Geneva, Switzerland on 15-16 November 2016. In the lead up to the closure of GAP an online questionnaire has been issued. Please click on the link below for more information about the meeting and to access the questionnaire.
21 August 2015
The report of the 10th GAP Advisory Group meeting held 19 March 2015 in Sao Paulo, Brazil is now available.
11 June 2015
GAP presented at Second APACI Summit
An update on GAP was provided during the 2nd Asia-Pacific Influenza Summit in Hanoi, Viet Nam. Since 2006, GAP has supported Viet Nam in establishing pandemic and seasonal influenza vaccine production and regulatory capacity.
World Health Organization
Global Action Plan for Influenza Vaccines (GAP)
20, avenue Appia
1211 Geneva 27, Switzerland
Key WHO Information
Director-General and senior management
Governance of WHO
WHO Constitution, Executive Board and World Health Assembly
News, events, fact sheets, multimedia and contacts
International travel and health
Publication on travel risks, precautions and vaccination requirements
World Health Report
Annual report on global public health and key statistics